nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Dactinomycin—germ cell cancer	0.249	0.39	CbGbCtD
Zoledronate—ABCC1—Vinblastine—germ cell cancer	0.156	0.244	CbGbCtD
Zoledronate—ABCC1—Etoposide—germ cell cancer	0.14	0.22	CbGbCtD
Zoledronate—ABCC1—Methotrexate—germ cell cancer	0.0927	0.145	CbGbCtD
Zoledronate—GGPS1—trigeminal ganglion—germ cell cancer	0.00498	0.0378	CbGeAlD
Zoledronate—GGPS1—brainstem—germ cell cancer	0.00441	0.0335	CbGeAlD
Zoledronate—GGPS1—retina—germ cell cancer	0.00425	0.0323	CbGeAlD
Zoledronate—GGPS1—telencephalon—germ cell cancer	0.00391	0.0297	CbGeAlD
Zoledronate—GGPS1—decidua—germ cell cancer	0.00371	0.0282	CbGeAlD
Zoledronate—GGPS1—gonad—germ cell cancer	0.00326	0.0248	CbGeAlD
Zoledronate—GGPS1—uterus—germ cell cancer	0.00324	0.0246	CbGeAlD
Zoledronate—GGPS1—pituitary gland—germ cell cancer	0.00318	0.0242	CbGeAlD
Zoledronate—GGPS1—medulla oblongata—germ cell cancer	0.00307	0.0233	CbGeAlD
Zoledronate—GGPS1—adrenal gland—germ cell cancer	0.00284	0.0216	CbGeAlD
Zoledronate—GGPS1—midbrain—germ cell cancer	0.00281	0.0213	CbGeAlD
Zoledronate—GGPS1—bone marrow—germ cell cancer	0.00275	0.0209	CbGeAlD
Zoledronate—GGPS1—spinal cord—germ cell cancer	0.00274	0.0208	CbGeAlD
Zoledronate—GGPS1—female gonad—germ cell cancer	0.00265	0.0201	CbGeAlD
Zoledronate—GGPS1—endocrine gland—germ cell cancer	0.00247	0.0187	CbGeAlD
Zoledronate—GGPS1—head—germ cell cancer	0.00243	0.0185	CbGeAlD
Zoledronate—GGPS1—testis—germ cell cancer	0.00235	0.0179	CbGeAlD
Zoledronate—CA14—telencephalon—germ cell cancer	0.00234	0.0178	CbGeAlD
Zoledronate—FDPS—trigeminal ganglion—germ cell cancer	0.0023	0.0174	CbGeAlD
Zoledronate—GGPS1—cerebellum—germ cell cancer	0.00217	0.0165	CbGeAlD
Zoledronate—CA12—eye—germ cell cancer	0.002	0.0152	CbGeAlD
Zoledronate—FDPS—eye—germ cell cancer	0.00198	0.015	CbGeAlD
Zoledronate—CA14—medulla oblongata—germ cell cancer	0.00184	0.0139	CbGeAlD
Zoledronate—CA12—telencephalon—germ cell cancer	0.00182	0.0138	CbGeAlD
Zoledronate—FDPS—telencephalon—germ cell cancer	0.0018	0.0137	CbGeAlD
Zoledronate—GGPS1—brain—germ cell cancer	0.00176	0.0134	CbGeAlD
Zoledronate—FDPS—skin of body—germ cell cancer	0.00172	0.0131	CbGeAlD
Zoledronate—FDPS—decidua—germ cell cancer	0.00171	0.013	CbGeAlD
Zoledronate—GGPS1—lymph node—germ cell cancer	0.0017	0.013	CbGeAlD
Zoledronate—CA14—adrenal gland—germ cell cancer	0.0017	0.0129	CbGeAlD
Zoledronate—CA14—midbrain—germ cell cancer	0.00168	0.0127	CbGeAlD
Zoledronate—CA14—spinal cord—germ cell cancer	0.00164	0.0124	CbGeAlD
Zoledronate—FDPS—gonad—germ cell cancer	0.0015	0.0114	CbGeAlD
Zoledronate—FDPS—uterus—germ cell cancer	0.00149	0.0114	CbGeAlD
Zoledronate—FDPS—pituitary gland—germ cell cancer	0.00147	0.0111	CbGeAlD
Zoledronate—FDPS—medulla oblongata—germ cell cancer	0.00142	0.0108	CbGeAlD
Zoledronate—CA2—neck—germ cell cancer	0.00138	0.0105	CbGeAlD
Zoledronate—FDPS—adrenal gland—germ cell cancer	0.00131	0.00996	CbGeAlD
Zoledronate—CA14—cerebellum—germ cell cancer	0.0013	0.00986	CbGeAlD
Zoledronate—FDPS—midbrain—germ cell cancer	0.00129	0.00983	CbGeAlD
Zoledronate—FDPS—bone marrow—germ cell cancer	0.00127	0.00963	CbGeAlD
Zoledronate—FDPS—spinal cord—germ cell cancer	0.00126	0.00959	CbGeAlD
Zoledronate—FDPS—female gonad—germ cell cancer	0.00122	0.00929	CbGeAlD
Zoledronate—CA2—trigeminal ganglion—germ cell cancer	0.00119	0.00905	CbGeAlD
Zoledronate—CA2—embryo—germ cell cancer	0.00115	0.00874	CbGeAlD
Zoledronate—CA12—endocrine gland—germ cell cancer	0.00115	0.00873	CbGeAlD
Zoledronate—FDPS—endocrine gland—germ cell cancer	0.00114	0.00864	CbGeAlD
Zoledronate—CA12—head—germ cell cancer	0.00113	0.00862	CbGeAlD
Zoledronate—FDPS—head—germ cell cancer	0.00112	0.00853	CbGeAlD
Zoledronate—FDPS—testis—germ cell cancer	0.00108	0.00824	CbGeAlD
Zoledronate—CA14—brain—germ cell cancer	0.00105	0.00801	CbGeAlD
Zoledronate—CA2—brainstem—germ cell cancer	0.00105	0.00801	CbGeAlD
Zoledronate—ABCC1—telencephalon—germ cell cancer	0.00105	0.00795	CbGeAlD
Zoledronate—CA2—eye—germ cell cancer	0.00103	0.0078	CbGeAlD
Zoledronate—CA2—retina—germ cell cancer	0.00102	0.00773	CbGeAlD
Zoledronate—FDPS—cerebellum—germ cell cancer	0.001	0.00761	CbGeAlD
Zoledronate—ABCC1—decidua—germ cell cancer	0.000992	0.00754	CbGeAlD
Zoledronate—CA2—telencephalon—germ cell cancer	0.000936	0.00711	CbGeAlD
Zoledronate—CA2—skin of body—germ cell cancer	0.000893	0.00678	CbGeAlD
Zoledronate—CA2—decidua—germ cell cancer	0.000887	0.00674	CbGeAlD
Zoledronate—ABCC1—uterus—germ cell cancer	0.000868	0.00659	CbGeAlD
Zoledronate—ABCC1—pituitary gland—germ cell cancer	0.000852	0.00647	CbGeAlD
Zoledronate—CA12—brain—germ cell cancer	0.000822	0.00625	CbGeAlD
Zoledronate—FDPS—brain—germ cell cancer	0.000813	0.00618	CbGeAlD
Zoledronate—FDPS—lymph node—germ cell cancer	0.000786	0.00597	CbGeAlD
Zoledronate—CA2—pituitary gland—germ cell cancer	0.000762	0.00579	CbGeAlD
Zoledronate—ABCC1—adrenal gland—germ cell cancer	0.000761	0.00578	CbGeAlD
Zoledronate—CA2—medulla oblongata—germ cell cancer	0.000735	0.00558	CbGeAlD
Zoledronate—ABCC1—female gonad—germ cell cancer	0.00071	0.00539	CbGeAlD
Zoledronate—CA2—adrenal gland—germ cell cancer	0.000681	0.00517	CbGeAlD
Zoledronate—CA2—midbrain—germ cell cancer	0.000672	0.0051	CbGeAlD
Zoledronate—CA2—bone marrow—germ cell cancer	0.000659	0.005	CbGeAlD
Zoledronate—CA2—spinal cord—germ cell cancer	0.000656	0.00498	CbGeAlD
Zoledronate—CA2—female gonad—germ cell cancer	0.000635	0.00482	CbGeAlD
Zoledronate—ABCC1—testis—germ cell cancer	0.00063	0.00478	CbGeAlD
Zoledronate—CA2—endocrine gland—germ cell cancer	0.00059	0.00448	CbGeAlD
Zoledronate—CA2—head—germ cell cancer	0.000583	0.00443	CbGeAlD
Zoledronate—ABCC1—cerebellum—germ cell cancer	0.000582	0.00442	CbGeAlD
Zoledronate—CA2—testis—germ cell cancer	0.000563	0.00428	CbGeAlD
Zoledronate—CA2—cerebellum—germ cell cancer	0.00052	0.00395	CbGeAlD
Zoledronate—ABCC1—brain—germ cell cancer	0.000472	0.00359	CbGeAlD
Zoledronate—ABCC1—lymph node—germ cell cancer	0.000456	0.00347	CbGeAlD
Zoledronate—CA2—brain—germ cell cancer	0.000422	0.00321	CbGeAlD
Zoledronate—CA2—lymph node—germ cell cancer	0.000408	0.0031	CbGeAlD
Zoledronate—Cough—Ifosfamide—germ cell cancer	0.000397	0.00172	CcSEcCtD
Zoledronate—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000396	0.00172	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000396	0.00171	CcSEcCtD
Zoledronate—Convulsion—Ifosfamide—germ cell cancer	0.000394	0.0017	CcSEcCtD
Zoledronate—Hypertension—Ifosfamide—germ cell cancer	0.000393	0.0017	CcSEcCtD
Zoledronate—Erythema—Cisplatin—germ cell cancer	0.000392	0.0017	CcSEcCtD
Zoledronate—Malnutrition—Cisplatin—germ cell cancer	0.000392	0.0017	CcSEcCtD
Zoledronate—Paraesthesia—Bleomycin—germ cell cancer	0.00039	0.00169	CcSEcCtD
Zoledronate—Dyspnoea—Bleomycin—germ cell cancer	0.000387	0.00167	CcSEcCtD
Zoledronate—Arthralgia—Ifosfamide—germ cell cancer	0.000387	0.00167	CcSEcCtD
Zoledronate—Chest pain—Ifosfamide—germ cell cancer	0.000387	0.00167	CcSEcCtD
Zoledronate—Myalgia—Ifosfamide—germ cell cancer	0.000387	0.00167	CcSEcCtD
Zoledronate—Renal failure acute—Methotrexate—germ cell cancer	0.000387	0.00167	CcSEcCtD
Zoledronate—Anorexia—Dactinomycin—germ cell cancer	0.000386	0.00167	CcSEcCtD
Zoledronate—Eye disorder—Etoposide—germ cell cancer	0.000386	0.00167	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000384	0.00166	CcSEcCtD
Zoledronate—Flushing—Etoposide—germ cell cancer	0.000383	0.00166	CcSEcCtD
Zoledronate—Cardiac disorder—Etoposide—germ cell cancer	0.000383	0.00166	CcSEcCtD
Zoledronate—Discomfort—Ifosfamide—germ cell cancer	0.000382	0.00165	CcSEcCtD
Zoledronate—Hypersensitivity—Vinblastine—germ cell cancer	0.000379	0.00164	CcSEcCtD
Zoledronate—Decreased appetite—Bleomycin—germ cell cancer	0.000377	0.00163	CcSEcCtD
Zoledronate—Muscle spasms—Cisplatin—germ cell cancer	0.000377	0.00163	CcSEcCtD
Zoledronate—Angiopathy—Etoposide—germ cell cancer	0.000374	0.00162	CcSEcCtD
Zoledronate—Confusional state—Ifosfamide—germ cell cancer	0.000374	0.00162	CcSEcCtD
Zoledronate—Immune system disorder—Etoposide—germ cell cancer	0.000373	0.00161	CcSEcCtD
Zoledronate—Mediastinal disorder—Etoposide—germ cell cancer	0.000372	0.00161	CcSEcCtD
Zoledronate—Pain—Bleomycin—germ cell cancer	0.000371	0.00161	CcSEcCtD
Zoledronate—Oedema—Ifosfamide—germ cell cancer	0.000371	0.00161	CcSEcCtD
Zoledronate—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000371	0.00161	CcSEcCtD
Zoledronate—Chills—Etoposide—germ cell cancer	0.00037	0.0016	CcSEcCtD
Zoledronate—Vision blurred—Cisplatin—germ cell cancer	0.000369	0.0016	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000369	0.0016	CcSEcCtD
Zoledronate—Asthenia—Vinblastine—germ cell cancer	0.000369	0.0016	CcSEcCtD
Zoledronate—Infection—Ifosfamide—germ cell cancer	0.000369	0.0016	CcSEcCtD
Zoledronate—Tremor—Cisplatin—germ cell cancer	0.000367	0.00159	CcSEcCtD
Zoledronate—Alopecia—Etoposide—germ cell cancer	0.000365	0.00158	CcSEcCtD
Zoledronate—Lethargy—Methotrexate—germ cell cancer	0.000364	0.00158	CcSEcCtD
Zoledronate—Nervous system disorder—Ifosfamide—germ cell cancer	0.000364	0.00157	CcSEcCtD
Zoledronate—Ill-defined disorder—Cisplatin—germ cell cancer	0.000364	0.00157	CcSEcCtD
Zoledronate—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000363	0.00157	CcSEcCtD
Zoledronate—Anaemia—Cisplatin—germ cell cancer	0.000362	0.00157	CcSEcCtD
Zoledronate—Skin disorder—Ifosfamide—germ cell cancer	0.00036	0.00156	CcSEcCtD
Zoledronate—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000359	0.00155	CcSEcCtD
Zoledronate—Feeling abnormal—Bleomycin—germ cell cancer	0.000358	0.00155	CcSEcCtD
Zoledronate—Osteoarthritis—Methotrexate—germ cell cancer	0.000357	0.00155	CcSEcCtD
Zoledronate—Anorexia—Ifosfamide—germ cell cancer	0.000354	0.00153	CcSEcCtD
Zoledronate—Malaise—Cisplatin—germ cell cancer	0.000353	0.00153	CcSEcCtD
Zoledronate—Decreased appetite—Dactinomycin—germ cell cancer	0.000352	0.00152	CcSEcCtD
Zoledronate—Diarrhoea—Vinblastine—germ cell cancer	0.000352	0.00152	CcSEcCtD
Zoledronate—Dysgeusia—Etoposide—germ cell cancer	0.000352	0.00152	CcSEcCtD
Zoledronate—Leukopenia—Cisplatin—germ cell cancer	0.000351	0.00152	CcSEcCtD
Zoledronate—Fatigue—Dactinomycin—germ cell cancer	0.000349	0.00151	CcSEcCtD
Zoledronate—Back pain—Etoposide—germ cell cancer	0.000347	0.0015	CcSEcCtD
Zoledronate—Hypotension—Ifosfamide—germ cell cancer	0.000347	0.0015	CcSEcCtD
Zoledronate—Pain—Dactinomycin—germ cell cancer	0.000346	0.0015	CcSEcCtD
Zoledronate—Muscle spasms—Etoposide—germ cell cancer	0.000345	0.00149	CcSEcCtD
Zoledronate—Urticaria—Bleomycin—germ cell cancer	0.000345	0.00149	CcSEcCtD
Zoledronate—Body temperature increased—Bleomycin—germ cell cancer	0.000343	0.00149	CcSEcCtD
Zoledronate—Dizziness—Vinblastine—germ cell cancer	0.00034	0.00147	CcSEcCtD
Zoledronate—Convulsion—Cisplatin—germ cell cancer	0.00034	0.00147	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000338	0.00146	CcSEcCtD
Zoledronate—Myalgia—Cisplatin—germ cell cancer	0.000334	0.00144	CcSEcCtD
Zoledronate—Feeling abnormal—Dactinomycin—germ cell cancer	0.000334	0.00144	CcSEcCtD
Zoledronate—Paraesthesia—Ifosfamide—germ cell cancer	0.000333	0.00144	CcSEcCtD
Zoledronate—Ill-defined disorder—Etoposide—germ cell cancer	0.000333	0.00144	CcSEcCtD
Zoledronate—Anxiety—Cisplatin—germ cell cancer	0.000333	0.00144	CcSEcCtD
Zoledronate—Anaemia—Etoposide—germ cell cancer	0.000332	0.00144	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000331	0.00143	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000331	0.00143	CcSEcCtD
Zoledronate—Dyspnoea—Ifosfamide—germ cell cancer	0.000331	0.00143	CcSEcCtD
Zoledronate—Somnolence—Ifosfamide—germ cell cancer	0.00033	0.00143	CcSEcCtD
Zoledronate—Discomfort—Cisplatin—germ cell cancer	0.00033	0.00143	CcSEcCtD
Zoledronate—Vomiting—Vinblastine—germ cell cancer	0.000327	0.00141	CcSEcCtD
Zoledronate—Malaise—Etoposide—germ cell cancer	0.000324	0.0014	CcSEcCtD
Zoledronate—Vertigo—Etoposide—germ cell cancer	0.000323	0.0014	CcSEcCtD
Zoledronate—Decreased appetite—Ifosfamide—germ cell cancer	0.000323	0.0014	CcSEcCtD
Zoledronate—Headache—Vinblastine—germ cell cancer	0.000322	0.00139	CcSEcCtD
Zoledronate—Leukopenia—Etoposide—germ cell cancer	0.000321	0.00139	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00032	0.00139	CcSEcCtD
Zoledronate—Abdominal pain—Dactinomycin—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Body temperature increased—Dactinomycin—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Fatigue—Ifosfamide—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Oedema—Cisplatin—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Anaphylactic shock—Cisplatin—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Hypersensitivity—Bleomycin—germ cell cancer	0.00032	0.00138	CcSEcCtD
Zoledronate—Infection—Cisplatin—germ cell cancer	0.000318	0.00138	CcSEcCtD
Zoledronate—Pain—Ifosfamide—germ cell cancer	0.000317	0.00137	CcSEcCtD
Zoledronate—Constipation—Ifosfamide—germ cell cancer	0.000317	0.00137	CcSEcCtD
Zoledronate—Loss of consciousness—Etoposide—germ cell cancer	0.000316	0.00137	CcSEcCtD
Zoledronate—Nervous system disorder—Cisplatin—germ cell cancer	0.000314	0.00136	CcSEcCtD
Zoledronate—Cough—Etoposide—germ cell cancer	0.000313	0.00136	CcSEcCtD
Zoledronate—Thrombocytopenia—Cisplatin—germ cell cancer	0.000313	0.00136	CcSEcCtD
Zoledronate—Tachycardia—Cisplatin—germ cell cancer	0.000312	0.00135	CcSEcCtD
Zoledronate—Asthenia—Bleomycin—germ cell cancer	0.000312	0.00135	CcSEcCtD
Zoledronate—Convulsion—Etoposide—germ cell cancer	0.000311	0.00135	CcSEcCtD
Zoledronate—Skin disorder—Cisplatin—germ cell cancer	0.000311	0.00134	CcSEcCtD
Zoledronate—Hypertension—Etoposide—germ cell cancer	0.00031	0.00134	CcSEcCtD
Zoledronate—Hyperhidrosis—Cisplatin—germ cell cancer	0.000309	0.00134	CcSEcCtD
Zoledronate—Asthma—Methotrexate—germ cell cancer	0.000309	0.00134	CcSEcCtD
Zoledronate—Pruritus—Bleomycin—germ cell cancer	0.000307	0.00133	CcSEcCtD
Zoledronate—Feeling abnormal—Ifosfamide—germ cell cancer	0.000306	0.00132	CcSEcCtD
Zoledronate—Chest pain—Etoposide—germ cell cancer	0.000306	0.00132	CcSEcCtD
Zoledronate—Nausea—Vinblastine—germ cell cancer	0.000305	0.00132	CcSEcCtD
Zoledronate—Anorexia—Cisplatin—germ cell cancer	0.000305	0.00132	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000304	0.00131	CcSEcCtD
Zoledronate—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000303	0.00131	CcSEcCtD
Zoledronate—Discomfort—Etoposide—germ cell cancer	0.000302	0.00131	CcSEcCtD
Zoledronate—Hypotension—Cisplatin—germ cell cancer	0.000299	0.00129	CcSEcCtD
Zoledronate—Hypersensitivity—Dactinomycin—germ cell cancer	0.000298	0.00129	CcSEcCtD
Zoledronate—Abdominal discomfort—Methotrexate—germ cell cancer	0.000296	0.00128	CcSEcCtD
Zoledronate—Confusional state—Etoposide—germ cell cancer	0.000296	0.00128	CcSEcCtD
Zoledronate—Urticaria—Ifosfamide—germ cell cancer	0.000295	0.00128	CcSEcCtD
Zoledronate—Abdominal pain—Ifosfamide—germ cell cancer	0.000293	0.00127	CcSEcCtD
Zoledronate—Body temperature increased—Ifosfamide—germ cell cancer	0.000293	0.00127	CcSEcCtD
Zoledronate—Pancytopenia—Methotrexate—germ cell cancer	0.000293	0.00127	CcSEcCtD
Zoledronate—Anaphylactic shock—Etoposide—germ cell cancer	0.000293	0.00127	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000291	0.00126	CcSEcCtD
Zoledronate—Infection—Etoposide—germ cell cancer	0.000291	0.00126	CcSEcCtD
Zoledronate—Asthenia—Dactinomycin—germ cell cancer	0.000291	0.00126	CcSEcCtD
Zoledronate—Neutropenia—Methotrexate—germ cell cancer	0.000289	0.00125	CcSEcCtD
Zoledronate—Paraesthesia—Cisplatin—germ cell cancer	0.000287	0.00124	CcSEcCtD
Zoledronate—Thrombocytopenia—Etoposide—germ cell cancer	0.000287	0.00124	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000287	0.00124	CcSEcCtD
Zoledronate—Tachycardia—Etoposide—germ cell cancer	0.000286	0.00124	CcSEcCtD
Zoledronate—Dyspnoea—Cisplatin—germ cell cancer	0.000285	0.00123	CcSEcCtD
Zoledronate—Skin disorder—Etoposide—germ cell cancer	0.000285	0.00123	CcSEcCtD
Zoledronate—Hyperhidrosis—Etoposide—germ cell cancer	0.000283	0.00123	CcSEcCtD
Zoledronate—Anorexia—Etoposide—germ cell cancer	0.000279	0.00121	CcSEcCtD
Zoledronate—Decreased appetite—Cisplatin—germ cell cancer	0.000278	0.0012	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—germ cell cancer	0.000277	0.0012	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000276	0.00119	CcSEcCtD
Zoledronate—Vomiting—Bleomycin—germ cell cancer	0.000276	0.00119	CcSEcCtD
Zoledronate—Infestation NOS—Methotrexate—germ cell cancer	0.000275	0.00119	CcSEcCtD
Zoledronate—Infestation—Methotrexate—germ cell cancer	0.000275	0.00119	CcSEcCtD
Zoledronate—Depression—Methotrexate—germ cell cancer	0.000274	0.00119	CcSEcCtD
Zoledronate—Hypotension—Etoposide—germ cell cancer	0.000274	0.00118	CcSEcCtD
Zoledronate—Rash—Bleomycin—germ cell cancer	0.000274	0.00118	CcSEcCtD
Zoledronate—Pain—Cisplatin—germ cell cancer	0.000274	0.00118	CcSEcCtD
Zoledronate—Dermatitis—Bleomycin—germ cell cancer	0.000274	0.00118	CcSEcCtD
Zoledronate—Hypersensitivity—Ifosfamide—germ cell cancer	0.000273	0.00118	CcSEcCtD
Zoledronate—Renal failure—Methotrexate—germ cell cancer	0.000271	0.00117	CcSEcCtD
Zoledronate—Stomatitis—Methotrexate—germ cell cancer	0.000268	0.00116	CcSEcCtD
Zoledronate—Conjunctivitis—Methotrexate—germ cell cancer	0.000268	0.00116	CcSEcCtD
Zoledronate—Asthenia—Ifosfamide—germ cell cancer	0.000266	0.00115	CcSEcCtD
Zoledronate—Feeling abnormal—Cisplatin—germ cell cancer	0.000264	0.00114	CcSEcCtD
Zoledronate—Paraesthesia—Etoposide—germ cell cancer	0.000263	0.00114	CcSEcCtD
Zoledronate—Pruritus—Ifosfamide—germ cell cancer	0.000263	0.00114	CcSEcCtD
Zoledronate—Haematuria—Methotrexate—germ cell cancer	0.000262	0.00114	CcSEcCtD
Zoledronate—Dyspnoea—Etoposide—germ cell cancer	0.000261	0.00113	CcSEcCtD
Zoledronate—Somnolence—Etoposide—germ cell cancer	0.000261	0.00113	CcSEcCtD
Zoledronate—Nausea—Bleomycin—germ cell cancer	0.000258	0.00112	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—germ cell cancer	0.000257	0.00111	CcSEcCtD
Zoledronate—Agranulocytosis—Methotrexate—germ cell cancer	0.000257	0.00111	CcSEcCtD
Zoledronate—Rash—Dactinomycin—germ cell cancer	0.000255	0.0011	CcSEcCtD
Zoledronate—Decreased appetite—Etoposide—germ cell cancer	0.000255	0.0011	CcSEcCtD
Zoledronate—Diarrhoea—Ifosfamide—germ cell cancer	0.000254	0.0011	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000253	0.00109	CcSEcCtD
Zoledronate—Body temperature increased—Cisplatin—germ cell cancer	0.000253	0.00109	CcSEcCtD
Zoledronate—Fatigue—Etoposide—germ cell cancer	0.000253	0.00109	CcSEcCtD
Zoledronate—Pain—Etoposide—germ cell cancer	0.000251	0.00108	CcSEcCtD
Zoledronate—Constipation—Etoposide—germ cell cancer	0.000251	0.00108	CcSEcCtD
Zoledronate—Dizziness—Ifosfamide—germ cell cancer	0.000245	0.00106	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—germ cell cancer	0.000244	0.00106	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—germ cell cancer	0.000242	0.00105	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—germ cell cancer	0.000242	0.00104	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—germ cell cancer	0.000241	0.00104	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—germ cell cancer	0.00024	0.00104	CcSEcCtD
Zoledronate—Vomiting—Ifosfamide—germ cell cancer	0.000236	0.00102	CcSEcCtD
Zoledronate—Hypersensitivity—Cisplatin—germ cell cancer	0.000236	0.00102	CcSEcCtD
Zoledronate—Rash—Ifosfamide—germ cell cancer	0.000234	0.00101	CcSEcCtD
Zoledronate—Dermatitis—Ifosfamide—germ cell cancer	0.000234	0.00101	CcSEcCtD
Zoledronate—Urticaria—Etoposide—germ cell cancer	0.000233	0.00101	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—germ cell cancer	0.000232	0.001	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—germ cell cancer	0.000232	0.001	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—germ cell cancer	0.000231	0.000999	CcSEcCtD
Zoledronate—Asthenia—Cisplatin—germ cell cancer	0.00023	0.000993	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—germ cell cancer	0.000229	0.000992	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—germ cell cancer	0.000224	0.00097	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—germ cell cancer	0.000223	0.000966	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—germ cell cancer	0.000223	0.000963	CcSEcCtD
Zoledronate—Chills—Methotrexate—germ cell cancer	0.000222	0.000959	CcSEcCtD
Zoledronate—Nausea—Ifosfamide—germ cell cancer	0.00022	0.000954	CcSEcCtD
Zoledronate—Diarrhoea—Cisplatin—germ cell cancer	0.000219	0.000947	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—germ cell cancer	0.000218	0.000945	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—germ cell cancer	0.000216	0.000937	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—germ cell cancer	0.000216	0.000934	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—germ cell cancer	0.000215	0.000931	CcSEcCtD
Zoledronate—Erythema—Methotrexate—germ cell cancer	0.000215	0.000931	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—germ cell cancer	0.000211	0.000911	CcSEcCtD
Zoledronate—Asthenia—Etoposide—germ cell cancer	0.00021	0.00091	CcSEcCtD
Zoledronate—Back pain—Methotrexate—germ cell cancer	0.000208	0.0009	CcSEcCtD
Zoledronate—Pruritus—Etoposide—germ cell cancer	0.000207	0.000897	CcSEcCtD
Zoledronate—Vomiting—Cisplatin—germ cell cancer	0.000203	0.00088	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—germ cell cancer	0.000203	0.000877	CcSEcCtD
Zoledronate—Rash—Cisplatin—germ cell cancer	0.000202	0.000873	CcSEcCtD
Zoledronate—Dermatitis—Cisplatin—germ cell cancer	0.000202	0.000872	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—germ cell cancer	0.000201	0.000868	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—germ cell cancer	0.0002	0.000863	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—germ cell cancer	0.000199	0.00086	CcSEcCtD
Zoledronate—Malaise—Methotrexate—germ cell cancer	0.000194	0.000839	CcSEcCtD
Zoledronate—Dizziness—Etoposide—germ cell cancer	0.000194	0.000839	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—germ cell cancer	0.000193	0.000836	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—germ cell cancer	0.000193	0.000833	CcSEcCtD
Zoledronate—Nausea—Cisplatin—germ cell cancer	0.00019	0.000822	CcSEcCtD
Zoledronate—Cough—Methotrexate—germ cell cancer	0.000188	0.000812	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—germ cell cancer	0.000186	0.000806	CcSEcCtD
Zoledronate—Vomiting—Etoposide—germ cell cancer	0.000186	0.000806	CcSEcCtD
Zoledronate—Rash—Etoposide—germ cell cancer	0.000185	0.0008	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—germ cell cancer	0.000185	0.000799	CcSEcCtD
Zoledronate—Headache—Etoposide—germ cell cancer	0.000184	0.000794	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—germ cell cancer	0.000183	0.000792	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—germ cell cancer	0.000183	0.000792	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—germ cell cancer	0.000183	0.000792	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000182	0.000787	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—germ cell cancer	0.000181	0.000783	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—germ cell cancer	0.000177	0.000766	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—germ cell cancer	0.000176	0.00076	CcSEcCtD
Zoledronate—Infection—Methotrexate—germ cell cancer	0.000174	0.000755	CcSEcCtD
Zoledronate—Nausea—Etoposide—germ cell cancer	0.000174	0.000753	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—germ cell cancer	0.000172	0.000745	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—germ cell cancer	0.000172	0.000744	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—germ cell cancer	0.000171	0.000738	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—germ cell cancer	0.00017	0.000734	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—germ cell cancer	0.000167	0.000724	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—germ cell cancer	0.000164	0.00071	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00016	0.000692	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—germ cell cancer	0.000159	0.000687	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—germ cell cancer	0.000158	0.000682	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—germ cell cancer	0.000157	0.000677	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—germ cell cancer	0.000156	0.000675	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—germ cell cancer	0.000155	0.000669	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—germ cell cancer	0.000153	0.00066	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000152	0.000656	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—germ cell cancer	0.000151	0.000655	CcSEcCtD
Zoledronate—Pain—Methotrexate—germ cell cancer	0.00015	0.00065	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—germ cell cancer	0.000145	0.000626	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000144	0.000621	CcSEcCtD
Zoledronate—Urticaria—Methotrexate—germ cell cancer	0.000139	0.000603	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—germ cell cancer	0.000139	0.0006	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—germ cell cancer	0.000139	0.0006	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—germ cell cancer	0.000129	0.00056	CcSEcCtD
Zoledronate—Asthenia—Methotrexate—germ cell cancer	0.000126	0.000545	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—germ cell cancer	0.000124	0.000537	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—germ cell cancer	0.00012	0.00052	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—germ cell cancer	0.000116	0.000502	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—germ cell cancer	0.000112	0.000483	CcSEcCtD
Zoledronate—Rash—Methotrexate—germ cell cancer	0.000111	0.000479	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—germ cell cancer	0.000111	0.000478	CcSEcCtD
Zoledronate—Headache—Methotrexate—germ cell cancer	0.00011	0.000476	CcSEcCtD
Zoledronate—Nausea—Methotrexate—germ cell cancer	0.000104	0.000451	CcSEcCtD
